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ABSTRACT The bacterial genus Staphylococcus comprises a large group of pathogenic
and nonpathogenic species associated with an array of host species. Staphylococci are
differentiated into coagulase-positive or coagulase-negative groups based on the capacity
to promote clotting of plasma, a phenotype historically associated with the ability to
cause disease. However, the genetic basis of this important diagnostic and pathogenic
trait across the genus has not been examined to date. Here, we selected 54 representa-
tive staphylococcal species and subspecies to examine coagulation of plasma derived
from six representative host species. In total, 13 staphylococcal species mediated coagu-
lation of plasma from at least one host species including one previously identified as
coagulase negative (Staphylococcus condimenti). Comparative genomic analysis revealed
that coagulase activity correlated with the presence of a gene (vwb) encoding the von
Willebrand binding protein (vWbp) whereas only the Staphylococcus aureus complex con-
tained a gene encoding staphylocoagulase (Coa), the classical mediator of coagulation.
Importantly, S. aureus retained vwb-dependent coagulase activity in an S. aureus strain
deleted for coa whereas deletion of vwb in Staphylococcus pseudintermedius resulted in
loss of coagulase activity. Whole-genome-based phylogenetic reconstruction of the
Staphylococcus genus revealed that the vwb gene has been acquired on at least four dif-
ferent occasions during the evolution of the Staphylococcus genus followed by allelic
diversification via mutation and recombination. Allelic variants of vWbp from selected
coagulase-positive staphylococci mediated coagulation in a host-dependent manner in-
dicative of host-adaptive evolution. Taken together, we have determined the genetic and
evolutionary basis of staphylococcal coagulation, revealing vWbp to be its archetypal
determinant.
IMPORTANCE The ability of some species of staphylococci to promote coagulation of
plasma is a key pathogenic and diagnostic trait. Here, we provide a comprehensive
analysis of the coagulase positivity of the staphylococci and its evolutionary genetic
basis. We demonstrate that the von Willebrand binding protein rather than staphylo-
coagulase is the archetypal coagulation factor of the staphylococci and that the vwb
gene has been acquired several times independently during the evolution of the
staphylococci. Subsequently, vwb has undergone adaptive diversification to facilitate
host-specific functionality. Our findings provide important insights into the evolution
of pathogenicity among the staphylococci and the genetic basis for a defining diag-
nostic phenotype.
KEYWORDS Staphylococcus, coagulase, coagulase-positive staphylococci, coagulation,
diagnostics, evolution, host specificity, phylogeny, von Willebrand binding protein
The Staphylococcus genus comprises at least 70 species and subspecies associatedwith an array of host species and habitats (1). The defining phenotype for the iden-
tification of the major human and animal pathogen Staphylococcus aureus has tradi-
tionally been coagulation of rabbit plasma. However, in addition to S. aureus there are
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eight described coagulase-positive staphylococci (CoPS) including Staphylococcus
argenteus, Staphylococcus cornubiensis, Staphylococcus delphini, Staphylococcus interme-
dius, Staphylococcus lutrae, Staphylococcus pseudintermedius, Staphylococcus coagulans,
and Staphylococcus schweitzeri, with Staphylococcus agnetis, Staphylococcus chromo-
genes, and Staphylococcus hyicus described as coagulase variable (2, 3). To date, the ba-
sis for the coagulation phenotype has been examined only for S. aureus with staphylo-
coagulase (Coa) considered to be the classical mediator of coagulation. However, the
von Willebrand binding protein (vWbp) also exhibits coagulase activity (4, 5). Of note, a
staphylococcal pathogenicity island (SaPI)-encoded vWbp associated with ruminant or
equine strains of S. aureus confers the ability to coagulate plasma from their cognate
host species, demonstrating a role for SaPI-encoded vWbp in host adaptation (6, 7).
For both S. aureus Coa and vWbp, which contain 26.3% amino acid identity in strain
Newman, the N-terminal D1 and D2 domains are sufficient for the coagulation of
plasma via the nonproteolytic activation of prothrombin, which in turn cleaves fibrino-
gen to form insoluble fibrin, thus promoting clot formation (Fig. 1) (8, 9). Allelic varia-
tion of the D1 and D2 domains in both Coa and vWbp is associated with attenuated
binding efficiencies to prothrombin from different host species, underpinning the host
species-dependent coagulation observed (5, 10–12). For S. aureus, mediators of coagu-
lation promote bacterial survival in fibrin clots, allowing persistence in a murine subcu-
taneous infection model and bacterial dissemination in a murine bloodstream infection
model (13–15). Both coa and vwb genes are also required for the development of kid-
ney microabscesses during invasive disease (14, 16, 17). The key role of both Coa and
vWbp in the pathogenesis of S. aureus disease suggests that the capacity for coagula-
tion of plasma by other staphylococci is likely to be relevant to pathogenicity (8).
A recent study used PCR to identify genes more similar to vwb than coa among four
non-aureus CoPS (18). Furthermore, a recombinant form of a protein encoded by
S. pseudintermedius orthologous to vWbp of S. aureus was demonstrated to have coag-
ulase activity (19). However, the evolutionary genetic and functional basis of the coag-
ulase phenotype for non-aureus staphylococci has not been examined to date.
Here, we perform a comprehensive analysis of the coagulation capacity of 54 repre-
sentative staphylococcal species and subspecies in plasma from multiple host species.
Combining comparative genomic, evolutionary, and functional analyses, we examined
FIG 1 Schematic protein domain structure of Coa and vWbp of S. aureus Newman. Both Coa and vWbp
contain N-terminal signal peptides (S) and prothrombin-binding D1 and D2 domains. The C-terminal sequence
of Coa contains a linker (L) followed by fibrinogen-binding repeats (R). The C-terminal sequence of vWbp
contains a von Willebrand factor binding region between two domains. In S. aureus Newman, Coa and vWbp
share 26.3% amino acid identity.
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the molecular basis for coagulation among CoPS. Importantly, we demonstrate that
vWbp is the archetypal coagulation factor of CoPS, whereas the classical Coa is limited
to members of the S. aureus complex only. Acquisition of the vwb gene occurred on
four independent occasions during the evolutionary history of the staphylococci and
was followed by diversification via recombination and host-specific functional speciali-
zation. Taken together, these findings reveal the evolutionary history of a key diagnos-
tic and pathogenic trait of staphylococci.
RESULTS
Comprehensive examination of CoPS and host species-associated coagulation.
Of the 71 known staphylococcal species and subspecies that comprise the Staphylococcus
genus (1), 12 are reported to mediate coagulation of rabbit plasma (2). However, our previ-
ous findings indicate host-dependent variation in susceptibility to plasma coagulation (6,
7). Here, we investigated the capacity for 51 representative staphylococcal species and 3
subspecies to mediate coagulation of plasma from six host species including human, ca-
nine, equine, porcine, avian, and rabbit (see Table S1 in the supplemental material). We
also included five Mammaliicoccus species previously classified as members of the family
Staphylococcaceae (20). A coagulation phenotype was observed for 13 staphylococcal spe-
cies in plasma from at least one host species (Table 1). Unexpectedly, Staphylococcus condi-
menti, previously determined to be coagulase negative (21), exhibited coagulation of
equine plasma. Considerable variation was observed in the capacity for different staphylo-
coccal species to coagulate plasma from different host species, with coagulation of human
plasma restricted to S. aureus, S. chromogenes, and S. schweitzeri (Table 1). Of note, S. condi-
menti and S. hyicus did not coagulate rabbit plasma (traditionally used for identifying the
coagulase phenotype in clinical diagnostic labs) but mediated coagulation of plasma from
other host species. Furthermore, the time to coagulation mediated by CoPS varied from 2
to 24 h according to host species (Table 1). In summary, this genus-wide analysis of coagu-
lation using plasma from multiple host species reveals considerable variation in the effi-
ciency of plasma coagulation depending on the host species and suggests a revision of
the group of CoPS to include S. condimenti.
The capacity for coagulase activity was acquired on multiple occasions during
the evolution of the staphylococci. To examine the distribution of CoPS species across
the staphylococcal phylogeny, we constructed the most comprehensive species phylogeny
to date based on 231 concatenated core genes present in 50 staphylococcal species (five of
which included two subspecies each) for which the whole-genome sequences were avail-
able (Table S2). CoPS are distributed into three distinct clades including the S. aureus com-
plex (S. aureus, S. argenteus, and S. schweitzeri [22]), the Hyicus group containing coagulase-
TABLE 1 Coagulase activity of staphylococci in plasma from six host species
Species Associated host
Coagulase activity in plasma typea:
Human Canine Equine Porcine Avian Rabbit
S. agnetis Bovine 2 1 1 111 2 1
S. argenteus Human 2 111 11 11 2 1111
S. aureus Human 1111 1 111 11 2 1111
S. chromogenes Bovine 111 111 2 2 2 111
S. coagulans Canine 2 11 11 2 11 111
S. condimenti Unknown 2 2 1 2 2 2
S. cornubiensis Human 2 111 1111 1111 111 1111
S. delphini Dolphin 2 111 11 111 1 111
S. hyicus Porcine 2 11 2 1111 2 2
S. intermedius Avian 2 111 2 2 2 1111
S. lutrae Otter 2 111 11 2 1 1111
S. pseudintermedius Feline 2 111 111 11 2 111
S. schweitzeri Monkey 1 1 1 2 2 1
aOnly species that demonstrated coagulation of any plasma type in all three biological replicates are shown.1,
11,111, and1111, coagulating activity observed after 24, 6, 4, or 2 h of incubation, respectively;2, no
coagulating activity detected after 24 h.
vWbp Is the Archetypal Coagulation Factor for CoPS















































variable species (S. hyicus, S. agnetis, and S. chromogenes [3, 23, 24]), and the Intermedius
group (S. intermedius, S. delphini, S. pseudintermedius, S. cornubiensis, Staphylococcus ursi, S.
lutrae, S. schleiferi, and S. coagulans [25–28]), as previously described (Fig. 2) (28–30).
To investigate the genetic basis for the coagulase-positive phenotype, we examined
the genus-wide distribution of genes known to encode proteins with coagulase activity
(Fig. 2). Unexpectedly, we found that the coa gene (encoding the classical staphylocoa-
gulase) was restricted to the S. aureus complex, but the vwb gene was identified
among all CoPS in addition to coagulase-negative staphylococcus (CoNS) S. schleiferi
(Fig. 2). The vwb genes were identified at distinct genomic locations in each coagulase-
positive clade, suggesting that acquisition occurred independently via horizontal trans-
fer on at least four occasions (Fig. 2). S. agnetis and S. hyicus each have two vwb copies
FIG 2 All CoPS species contain the vwb gene. Maximum likelihood phylogenetic tree of 50 staphylococcal species and 5
additional subspecies based on a core genome alignment of 231 concatenated genes. A list of the genome sequences used is
included in Table S2. Coagulase-positive species are highlighted in bold, and coagulase-variable species are highlighted with an
asterisk. Species containing the vwb gene are represented with orange branches, with orange circles indicating the branch on
which this gene was acquired. Red circles indicate the nodes in which additional vwb copies were acquired. The single acquisition
event of the coa gene by an ancestor of the S. aureus complex is indicated by a green circle. Genome locations of the vwb and
coa genes in each CoPS lineage are represented by colored bars on a blue ring depicting the chromosome. Support values are
shown on each branch and were calculated using the Shimodaira-Hasegawa test. The Mammaliicoccus cluster is the root of the
tree.
Pickering et al.















































in tandem, presumably as a result of a gene duplication event that occurred prior to
divergence of these two closely related species. S. lutrae also carries two copies of vwb,
one in the same genomic location as the other members of the Hyicus clade and the
second copy in a unique genomic location (Fig. 2). Taken together, we infer that vwb
was acquired on multiple occasions during the evolutionary history of the staphylo-
cocci, leading to the emergence of distinct groups of CoPS.
The presence of the vwb gene in S. condimenti (and the lack of a vwb gene in the
closely related species Staphylococcus carnosus) indicates an independent acquisition
during the evolution of this species, which correlates with the capacity to coagulate
equine plasma as identified in the current study (Table 1). The presence of the vwb
gene in both the Hyicus and Intermedius coagulase-positive clades, and the absence
of coa, suggested that vWbp may be the mediator of coagulation for these species.
vWbp diversification has occurred via mutation, recombination, and duplication.
To investigate the diversity and relatedness of the vwb and coa genes among the
CoPS, a phylogenetic tree was constructed based on sequences extracted from
genomes representing 41 non-S. aureus species (Table S2), and 802 S. aureus, S.
schweitzeri, and S. argenteus genomes (31). From those, we selected representative
copies of each phylogenetic cluster within the S. aureus complex to avoid redundancy,
leaving a total of 12 Coa and 129 vWbp protein sequences from 11 species across the
three CoPS clades (Fig. 3). vWbp sequences form four distinct clusters that correspond
to chromosomal genes from the Hyicus (n=8) and Intermedius (n= 32) clades, the S.
aureus complex (n=51), and SaPI-associated genes from S. aureus (n=37), respectively.
The only vWbp copy from the only S. condimenti genome was most closely related to
the Hyicus clade vWbp copies (Fig. 3). The vWbp clades are more closely related to
each other (34.7% average pairwise protein similarity between the full-length vWbp al-
leles of the Hyicus and Intermedius clades) than to the S. aureus Coa protein (22.6%
and 21.6% average pairwise protein similarity between the full-length Coa and vWbp
alleles of the Hyicus and Intermedius clades, respectively), which forms a monophyletic
clade indicating a distinct evolutionary history (Fig. 3; also see Table S3). The topology
of the vWbp Hyicus and Intermedius clades correlates with the species distribution in
the core genome-based Staphylococcus genus phylogeny (Fig. 2), consistent with an-
cient independent acquisition by progenitors of the Hyicus and Intermedius clades, fol-
lowed by evolution according to species and a low degree of interspecies gene
exchange (Fig. 3). The exception to this were the paralogous vwb genes in S. agnetis
and S. hyicus, which have distinct evolutionary histories compared to the ancestral
chromosomal copy, whereas the S. lutrae vwb copies clustered together in the phylog-
eny, consistent with gene duplication since speciation (Fig. 3).
Previously, it was shown that recombination has contributed to the evolution of the
coa genes among S. aureus isolates (12). In order to examine the impact of recombina-
tion on the evolutionary history of the vwb gene in the S. aureus complex, we
employed both RDP4 and FastGEAR analysis using a 100-bp sliding window approach
on 39 vwb gene sequences representing the breadth of sequence diversity. This analy-
sis revealed high levels of recombination affecting the N-terminal D1 and D2 coagula-
tion domains, explaining the lower pairwise protein similarity observed in the S. aureus
complex for the D1 and D2 domains, in comparison to full-length vWbp (Fig. 4;
Table S3). Of note, S. aureus complex chromosomal vwb copies exhibited extensive
sequence admixture between S. aureus, S. argenteus, and S. schweitzeri consistent with
a shared ecology providing opportunities for horizontal gene transfer and recombina-
tion (Fig. 4).
Taken together, we identified a complex evolutionary history of the vwb gene with
evidence for diversification of vwb in a species-dependent manner in the Hyicus and
Intermedius clades. In contrast, a high degree of recombination between the members
of the S. aureus complex has generated extensive allelic diversity of vwb.
vWbp is the archetypal coagulation factor of the staphylococci. From our phylo-
genetic analysis of the distribution of genes encoding coagulase activity, and the corre-
lation of the vwb gene with coagulase positivity, we hypothesized that vwb is the main
vWbp Is the Archetypal Coagulation Factor for CoPS















































mediator of coagulation in the Staphylococcus genus. To date, the capacity for vWbp
from non-aureus CoPS to mediate coagulation has not been tested. Accordingly, we
produced recombinant vWbp variants derived from CoPS species including human S.
aureus Newman, canine S. pseudintermedius ED99, avian S. intermedius ATCC 29663,
equine S. delphini 8086, and porcine S. hyicus ATCC 11249 in addition to Coa from
FIG 3 Staphylococcal vWbp has an evolutionary history distinct from that of coagulase. (A) Unrooted maximum-
likelihood tree constructed using FastTree v2 of the Coa and vWbp protein sequences. Each of the main clusters is
highlighted and labeled. Coagulase positivity has evolved on multiple occasions through acquisition of vwb followed
by evolution according to species. (B) Phylogenetic reconstruction of the non-aureus CoPS based on vWbp protein
sequences.
Pickering et al.















































S. aureus Newman and tested their capacity to promote coagulation of plasma from an
array of different host species in dose-dependent assays (Fig. 5; Table 2; Fig. S1 to S3)
(23, 32–35). Each variant had the capacity to mediate plasma coagulation from their
cognate host species, though there was considerable variation in the capacity to coag-
ulate plasma from other species (Fig. 5; Table 2). Overall, the activity was similar to that
observed for the parent bacterial species (Table 1), consistent with vWbp being the key
mediator of coagulation in non-aureus staphylococci.
To confirm this in a representative CoPS species of clinical relevance, we constructed
a vwb deletion mutant in S. pseudintermedius ED99 (34), reintroduced the vwb gene to
produce a repaired derivative strain, and also employed single and double mutants of
vwb and coa in S. aureus strain Newman (16). Single deletions of the vwb and coa genes
in S. aureus Newman did not ablate plasma coagulation, with deletion of both genes
required for loss of the coagulation phenotype (Fig. 6A). In contrast, deletion of vwb in S.
pseudintermedius (ED99Dvwb) resulted in loss of ability to coagulate plasma after 24 h
whereas the isogenic wild-type and ED99Dvwb repaired strain produced complete clots
FIG 4 The chromosomal vwb has undergone extensive recombination among the S. aureus complex species. Midpoint-rooted maximum-likelihood tree
constructed using FastTree v2 of the S. aureus complex vwb nucleotide sequences. Colored circles denote each Staphylococcus species. Plot of the
FastGEAR analysis of the vwb nucleotide alignment applied to 100-bp-long windows. For each window (i.e., column in the plot), each color represents
different phylogenetic clusters based on the BAPS algorithm. The axis at the top shows, for reference, the location of the coagulase (D11D2) domain using
the amino acid coordinates of the RF122 S. aureus isolate vWbp.
vWbp Is the Archetypal Coagulation Factor for CoPS















































after 2 h (Fig. 6A). Furthermore, antibodies specific for vWbppseudintermedius delayed coagu-
lation in a dose-dependent manner, confirming that vWbp mediates plasma coagulation
by S. pseudintermedius ED99 (Fig. 6B). These data demonstrate that vWbp is required for
the coagulase positivity of S. pseudintermedius ED99.
Taken together, these evolutionary and functional data support the hypothesis that
vWbp is the major determinant of coagulase positivity among staphylococci. For the S.
aureus complex species only, Coa provides redundancy in coagulase activity. In addi-
tion, allelic diversification has resulted in host-adaptive evolution supporting the
capacity of CoPS to adapt to different host niches.
DISCUSSION
The ability to coagulate plasma is considered a defining phenotype for the identifi-
cation of the major human pathogen S. aureus. Furthermore, the importance of
FIG 5 Recombinant vWbp proteins exhibit host-specific coagulation of plasma. Coagulation of plasma from human (A), canine (B), equine (C), porcine (D),
avian (E), and rabbit (F) origin by 50mg ml21 recombinant vWbp encoded by S. pseudintermedius (pink), S. intermedius (orange), S. delphini (dark green), S.
hyicus (light green), and S. aureus (blue), in addition to S. aureus Coa (purple). Coagulation was scored as 0.5 for trace levels of coagulation, 1.0 to 2.5 for
partially coagulating plasma, and 3.0 for a complete clot. Data are shown as the mean from 6 replicates with error bars representing standard deviation.
Pickering et al.















































coagulases Coa and vWbp in S. aureus pathogenesis is well established for catheter-
related biofilm formation and bacterial survival during bloodstream infections (13, 15,
36, 37). However, the evolutionary and genetic basis of coagulation for non-aureus
staphylococci or its role in pathogenesis had not been dissected previously. Here, we
have performed a comprehensive phylogenetic and functional analysis of coagulase
positivity among the staphylococci. The ability to coagulate plasma has evolved on
multiple occasions across the genus via independent acquisitions of the vwb gene
whereas the coa gene was likely acquired on a single occasion by an ancestor of the S.
aureus complex (Fig. 2). Our functional analyses demonstrated that the vwb gene iden-
tified among CoPS mediates coagulation of plasma in a host-dependent manner and is
solely responsible for the coagulase phenotype in a representative non-aureus species,
S. pseudintermedius (Fig. 5 and 6). Taken together, these data suggest that vWbp is the
archetypal coagulation factor of the Staphylococcus genus.
We identified extensive allelic diversity and recombination of the vwb gene among
members of the S. aureus complex (Fig. 3), consistent with an overlapping habitat for S.
aureus, S. argenteus, and S. schweitzeri (Fig. 4). A previous study has demonstrated
gene flow between S. aureus and S. argenteus via recombination, driven by a possible
shared ecological niche in livestock (38). In spite of the evidence for horizontal transfer
of vwb sequences, SaPI-encoded variants of vWbp were restricted to S. aureus, which
may reflect its multihost ecology and the role of vWbp in host adaptation (Fig. 3) (6).
However, whole-genome sequencing of other species is very limited compared to S.
aureus, and expanded sequencing of S. schweitzeri and S. argenteus isolates may reveal
novel variants. Of note, extensive variation and evidence for recombination have previ-
ously been reported for the coa gene of S. aureus and S. argenteus (12, 39, 40). In con-
trast, our vwb phylogenetic analysis for non-aureus staphylococci supported a model
of initial vwb gene acquisition followed by diversification according to species via
mutation rather than interspecies recombination (Fig. 3).
In order to examine the possibility that the allelic variation of vwb between staphy-
lococcal species in part reflected the independent evolution within distinct host ecolo-
gies, we examined the coagulase activity of recombinant vWbp from representative
CoPS species in plasma from six different host species. In each case, recombinant
vWbp variants exhibited coagulation of plasma from their cognate host species and
various levels of coagulation from other host species (Table 2; Fig. 5). The host species-
dependent activity of vWbp presumably reflects variation in the sequence of pro-
thrombin, the main substrate for vWbp (10, 11). Overall, these data indicate that vwb
has undergone adaptive evolution to facilitate functional activity in its preferred host
species, highlighting an important role for vWbp in host-pathogen interactions.
The coagulase test has been used since the 1940s to distinguish the virulent S. aur-
eus from less-virulent CoNS (41). Since the 1970s, additional CoPS have been identified,
largely associated with infections of animals (33), and the coagulase test has been
widely used in human and veterinary medicine. Although the coagulase test is still
commonly used, particularly in resource-poor settings around the world, molecular
TABLE 2Minimal concentration of recombinant vWbp or Coa protein required to coagulate
plasma after 24 h
Protein
Minimal concn (mg ml21) for plasma typea:
Human Canine Equine Porcine Avian Rabbit
Coaaureus 25 50 25
vWbpaureus 25 25 50 25 25
vWbpintermedius 25 5 25 25 5
vWbppseudintermedius 25 25 50 25
vWbpdelphini 5 5 25 25 5
vWbphyicus 25 50
aValues are the minimal concentration of recombinant protein required to induce coagulation after 24 h.
Recombinant protein was applied to PBS-diluted plasma at 50, 25, 5, or 1mg ml21.
vWbp Is the Archetypal Coagulation Factor for CoPS















































genetic or proteomic approaches have largely supplanted biochemical testing (42).
Our findings suggest that vwb sequence analysis to identify alleles associated with spe-
cific CoPS would offer a robust and simple diagnostic approach for the identification of
CoPS to species level and should be performed when describing novel staphylococcal
species. Of 14 species that contained a vwb gene, S. schleiferi was the only one which
FIG 6 vwb is required for the coagulase phenotype of S. pseudintermedius ED99. (A) Coagulation assay of wild-type and mutant
strains of S. pseudintermedius ED99 and S. aureus Newman in human and canine plasma. Average data are provided from three
biological replicates. (B) Antibody (Ab)-mediated inhibition of coagulation in canine plasma using ED99 wild type in the presence
of increasing concentrations of anti-vWbppseudintermedius antibody. The mean values are given from three experiments with error
bars representing standard deviation (n=3).
Pickering et al.















































did not exhibit a coagulase phenotype. This may reflect lack of gene expression or a
distinct host tropism that was not represented among the plasma samples included,
and analysis of additional isolates would be required to address this. Similarly, an
understanding of the genetic basis for the variation in coagulase positivity among
some staphylococcal species would require genomic analysis of more isolates. Of note,
we examined the genome sequences of the newly identified Staphylococcus durrellii,
Staphylococcus lloydii, and Staphylococcus pseudoxylosus type strains and did not identify
a vwb-like gene, consistent with their characterization as CoNS (43, 44). Furthermore,
the genome of the recently identified Staphylococcus ursi type strain MI 10-1553T,
reported as a CoNS of the otherwise coagulase-positive Intermedius clade, contains a
vwb-like remnant consistent with a deletion event that abrogated the ability to coagu-
late plasma (26).
In conclusion, the current study provides the first comprehensive genetic and func-
tional analysis of the coagulation capacity of the Staphylococcus genus. We propose
that vWbp, rather than Coa, is the archetypal coagulation factor of CoPS across the ge-
nus with the vwb gene acquired independently on multiple occasions, leading to dis-
tinct coagulase-positive clades within the Staphylococcus phylogeny. Diversification of
the vwb gene has occurred via mutation or recombination generating allelic diversity,
which in part reflects adaptive evolution to enable functionality of vWbp in the pre-
ferred host species, suggesting a key role in host-pathogen interactions. Taken to-
gether, our findings provide clarity into the evolutionary genetic and functional basis
for a defining diagnostic and pathogenic phenotype of the Staphylococcus genus.
MATERIALS ANDMETHODS
Phylogenetic analysis. Whole-genome sequences of the staphylococcal and mammaliicoccal type
strains were obtained from NCBI (see Table S2 in the supplemental material). Each genome was anno-
tated with Prokka v1.12 (45), and a core genome alignment was generated using Roary v3.12 (46), based
on a minimum percent identity cutoff of 80. The core genome alignment was then used to build a maxi-
mum likelihood phylogenetic tree with FastTree v2.1.7 (47). Coagulase and vWbp amino acid sequences
were extracted using Protein BLAST (blastp) from the reference whole-genome sequences from a ge-
nome sequence data set representative of the global S. aureus diversity (31). Sequences were aligned
using the ProbCons algorithm (48) implemented in Jalview v2 (49). Phylogenetic trees were constructed
using FastTree, and recombination analysis was performed using the programs Recombination
Detection Program (RDP4) (50) and FastGEAR (51). Average pairwise protein similarities were calculated
using MEGA X v10.1.8 (52) after classifying the D1 and D2 domains using the Conserved Domain
Database (53).
Coagulation assay. The bacterial strains used for coagulation assays are detailed in Table S1. All
strains were cultured overnight in brain heart infusion (BHI) broth at 37°C with shaking. For bacterial coag-
ulation assays, the cells were diluted in phosphate-buffered saline (PBS) to an optical density at 600 nm
(OD600) of 1.0. For recombinant protein coagulation assays, each recombinant protein was diluted in PBS
to the required concentration using the Nanodrop ND-1000 spectrophotometer. Plasma from all hosts was
sourced from SeraLab, Lampire, or BioIVT in sodium citrate and diluted 1:3 in PBS before use. Coagulation
was tested by mixing 190ml of diluted plasma with 10ml of recombinant protein or bacterial cells in sterile
borosilicate glass tubes. All coagulation assays were performed statically at 37°C in biological triplicate
with the level of coagulation observed at 1, 2, 4, 6, and 24 h by tilting the tubes. Antibody blocking of
coagulation was performed using IgY antibody generated against vWbppseudintermedius after lipopolysaccha-
ride (LPS) removal (Gallus Immunotech) at a concentration of 5, 2, 1, 0.5, or 0.1mg in the 200-ml reaction
mixture with concentrated supernatant.
Allelic replacement of S. pseudintermedius ED99. Mutant and repaired strains of S. pseudinterme-
dius ED99 were generated using the allele replacement plasmid pIMAY and the primers detailed in
Table S4, as described previously (54, 55). Briefly, the upstream and downstream flanking regions of the
vwb gene were amplified by PCR and annealed by splicing PCR to generate a deleted form of the gene.
For the repaired mutant, primers were designed to amplify the full-length vwb gene in addition to
upstream and downstream flanking regions with a synonymous mutation introduced into the vwb gene
to allow identification of the repaired strain in comparison to the wild type. Restriction digestion with
EcoRI (NEB) and T4 ligation (NEB) into pIMAY was carried out prior to transformation of the pIMAY::vwb
and pIMAY::vwb Rep constructs into Escherichia coli DC10B cells, followed by transformation into S. pseu-
dintermedius ED99 or ED99Dvwb. Allele replacement was performed as previously described (55), and
genetically manipulated strains were validated by whole-genome sequencing, growth analysis in BHI
using a FLUOstar Optima microplate reader (600 nm), and Western blot analysis of vWbp expression
using 5mg ml21 anti-vWbppseudintermedius IgY and 0.5mg ml21 F(ab9)2 rabbit anti-chicken IgG-horseradish
peroxidase (HRP) (Bethyl Laboratories).
Expression and purification of recombinant proteins. The N-terminal amino acids are important
for the function of coagulase, with N-terminal modification of vWbp impairing coagulation efficiency
vWbp Is the Archetypal Coagulation Factor for CoPS















































(56). In order to use the C-terminal His tag expression construct pET21b with the NheI site, all additional
plasmid N-terminal amino acids (Met-Ala-Ser-Met) were removed from the plasmid using pET21b-
specific primers (Table S4). This modified plasmid was used to clone vwbhyicus, vwbaureus, and coaaureus. All
pET21b constructs were produced using standard restriction digestion and NheI, NdeI, and XhoI (NEB)
and T4 ligase (NEB) procedures. Expression constructs were expressed in BL21(DE3) E. coli cells (NEB)
using 1mM isopropyl-b-D-thiogalactopyranoside (IPTG) for 4 h at 37°C. Cell lysates were produced at
20 kpsi using a One Shot cell disruptor (Constant Systems). All recombinant proteins underwent two pu-
rification steps using the high-performance liquid chromatography (HPLC) Äkta system (GE Healthcare):
first, immobilized metal affinity chromatography with 1ml Ni-nitrilotriacetic acid (NTA) superflow col-
umns (Qiagen) in either native or denaturing purification buffers, and second, ion-exchange chromatog-
raphy using Q Sepharose (GE Healthcare) for positively charged proteins or SP Sepharose (GE
Healthcare) for negatively charged proteins. All proteins were dialyzed to PBS using Float-A-Lyzers
(Spectrum Laboratories) and analyzed by SDS-PAGE.
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